Clabo disease

Krabbe disease was first reported by Danish pediatrician Krabbe in 1916. Therefore, it is called Krabbe disease. According to its clinical characteristics, it is also called infantile familial diffuse sclerosis, which is autosomal recessive Genetic metabolic disease, mutation gene is located at 14p. The deficiency of Krabbe's disease causes galactocerebroside-beta; -galactosidase deficiency, which is a genetic metabolic disease that mainly affects white matter in the brain. The disease has a poor prognosis. Infants often die within one year of age. Late-starters can survive to around 10 years of age.

The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.